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AbstrAct
Objective
To prospectively assess the construct and criterion 
validity of ClassIntra version 1.0, a newly developed 
classification for assessing intraoperative adverse 
events.
Design
International, multicentre cohort study.
setting
18 secondary and tertiary centres from 12 countries in 
Europe, Oceania, and North America.
ParticiPants
The cohort study included a representative sample of 
2520 patients in hospital having any type of surgery, 
followed up until discharge. A follow-up to assess 
mortality at 30 days was performed in 2372 patients 
(94%). A survey was sent to a representative sample 
of 163 surgeons and anaesthetists from participating 
centres.
Main OutcOMe Measures
Intraoperative complications were assessed 
according to ClassIntra. Postoperative complications 
were assessed daily until discharge from hospital 
with the Clavien-Dindo classification. The primary 
endpoint was construct validity by investigating the 
risk adjusted association between the most severe 
intraoperative and postoperative complications, 
measured in a multivariable hierarchical proportional 
odds model. For criterion validity, inter-rater reliability 
was evaluated in a survey of 10 fictitious case 
scenarios describing intraoperative complications.
results
Of 2520 patients enrolled, 610 (24%) experienced 
at least one intraoperative adverse event and 838 
(33%) at least one postoperative complication. 
Multivariable analysis showed a gradual increase in 
risk for a more severe postoperative complication 
with increasing grade of ClassIntra: ClassIntra grade 
I versus grade 0, odds ratio 0.99 (95% confidence 
interval 0.69 to 1.42); grade II versus grade 0, 1.39 
(0.97 to 2.00); grade III versus grade 0, 2.62 (1.31 
to 5.26); and grade IV versus grade 0, 3.81 (1.19 
to 12.2). ClassIntra showed high criterion validity 
with an intraclass correlation coefficient of 0.76 
(95% confidence interval 0.59 to 0.91) in the survey 
(response rate 83%).
cOnclusiOns
ClassIntra is the first prospectively validated 
classification for assessing intraoperative adverse 
events in a standardised way, linking them to 
postoperative complications with the well established 
Clavien-Dindo classification. ClassIntra can be 
incorporated into routine practice in perioperative 
surgical safety checklists, or used as a monitoring 
and outcome reporting tool for different surgical 
disciplines. Future studies should investigate whether 
the tool is useful to stratify patients to the appropriate 
postoperative care, to enhance the quality of surgical 





Over 310 million surgeries are conducted worldwide 
each year.1 One in six patients having elective surgery 
experiences at least one postoperative adverse 
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WhAt Is AlreAdy knoWn on thIs topIc
Intraoperative adverse events are a concern for patients, anaesthetists, and 
surgeons because of their association with adverse postoperative outcomes
In contrast with postoperative complications, prospectively validated systems for 
reporting intraoperative adverse events are lacking
Uniform definitions and transparent reporting of intraoperative adverse events 
are required for programmes to improve the safety of surgery and to compare 
results from clinical research
WhAt thIs study Adds
ClassIntra is the first prospectively validated classification system with good 
reliability and practicability that includes intraoperative adverse events related 
to surgery and anaesthesia
ClassIntra covers a major unmet need as it provides a standardised instrument to 
quantify and qualify intraoperative adverse events in clinical practice and clinical 
research for a range of surgical disciplines and for anaesthesia
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event.2 The growing annual surgical volume1 3 and 
the increasing complexity of comorbid conditions in 
patients having surgery4 5 has caused a rise in adverse 
events related to surgery. Intraoperative adverse 
events are associated with adverse outcomes,6-10 but 
in contrast with postoperative complications,11-13 a 
prospectively validated instrument for standardised 
and transparent reporting of intraoperative adverse 
events is lacking. Uniform definitions of perioperative 
outcomes, however, are required for programmes to 
improve the safety of surgery, for benchmarking, and 
to adequately compare results from clinical research.14
In 2015, our group developed a CLASSification 
of Intraoperative Complications (ClassIntra version 
1.0, formerly known as CLASSIC, supplementary 
table S1) in a Delphi process involving international, 
interdisciplinary experts, which was retrospectively 
validated.15 This tool defines intraoperative adverse 
events as any deviation from the ideal intraoperative 
course between skin incision and skin closure, and 
includes events related to surgery and anaesthesia. 
Similar to the widely used Clavien-Dindo classification 
for reporting postoperative complications (supplemen-
tary table S2),11 we sought to develop a generic 
classification, broadly applicable to all surgical 
disciplines, and including anaesthesia. To align 
with the validated Clavien-Dindo classification,16  17 
CLASSIC was updated by including five severity 
grades, maintaining the decision criterion on the need 
for treatment and severity of symptoms.
The aim of this international, multicentre, pro-
spective cohort study was to investigate the validity 
and practicability of the updated classification in 
many different surgical disciplines.
Methods
study oversight
This investigator initiated validation study of ClassIntra 
version 1.0 consisted of two parts. An international, 
multicentre, prospective cohort study was conducted 
in 18 centres in 12 countries in patients having any 
type of surgery requiring hospital admission for at 
least one night. The objective was to assess construct 
validity. Because no gold standard exists for the 
severity of intraoperative adverse events, we assessed 
the relation between the ClassIntra grades and other 
indirect measures that we expected to be related.18 
In particular, we investigated the stepwise increasing 
effect of the severity grades of ClassIntra and relevant 
postoperative outcomes, such as postoperative 
complications, length of hospital stay, and length 
of surgery. The second part involved a survey of 10 
fictitious case scenarios describing intraoperative 
adverse events. The survey was sent at the beginning 
of the prospective cohort study to physicians from 
the same international centres to grade severity. The 
aim was to assess criterion validity and reliability 
by comparing severity ratings by physicians with 
benchmark ratings set by the core team.
Across all centres, collaborators were trained in 
standardised data collection. Local study investigators 
confirmed the validity of the data from their centres. 
The results are reported according to STROBE 
(strengthening the reporting of observational studies 
in epidemiology).19
Patients and study procedures (prospective cohort 
study)
The centres prospectively included consecutive 
patients or a representative group of patients having 
any type of surgery from any surgical discipline. 
Excluded were day case surgeries, procedures not 
taking place in the operating room, procedures with no 
anaesthesia, and follow-up procedures.
The surgical and anaesthesia team prospectively 
recorded the severity grade and details of intraoperative 
adverse events that occurred between skin incision 
and skin closure, according to ClassIntra version 1.0 
(table 1), during team sign-out20 at the end of surgery. 
Disagreement was resolved by consensus. All patients 
were followed up until discharged from hospital and 
were assessed daily by the postoperative care team 
to identify and grade postoperative complications 
according to the Clavien-Dindo classification.11 
Because this was a pragmatic cohort study, performed 
during daily clinical practice, the postoperative 
team could not be blinded to the intraoperative 
adverse events, but was not aware of the ClassIntra 
grade. Postoperative complications after discharge, 
including mortality within 30 days, were assessed 
during structured follow-up visits or telephone calls to 
patients or their relatives.
Data describing the patients enrolled in the study 
were anonymised before entry into a secure web based 
electronic database. The database had automated 
checks for plausibility, consistency, and completeness 
of the data entries. Further consistency checks were 
performed after recruitment was finished.
classintra
ClassIntra version 1.0 was derived from CLASSIC,15 
which had four severity grades, but the same 
definition depending on the intervention required to 
treat the adverse event and the severity of symptoms 
(supplementary table S1). The only difference in 
the updated ClassIntra is that grade II has been 
divided into two grades. The additional grade (new 
grade III) describes a moderate deviation from the 
ideal course, which requires moderate treatment 
and results in severe symptoms. The rationale for 
updating the classification was to align with the 
number of grades in the Clavien-Dindo classification 
to avoid misclassification in grading intraoperative 
or postoperative death (supplementary table S2).11 A 
retrospective (unpublished) pilot study showed high 
reliability for ClassIntra.
We secured the rights to the ClassIntra classification 
by filing a trademark with the Swiss Federal Institute 
of Intellectual Property. The trademark was extended 
to relevant countries for our activities by inter-
national registration at the World Intellectual Property 
Organisation.
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Outcomes
The primary outcome was the association of the 
most severe intraoperative adverse events, according 
to ClassIntra, with the most severe postoperative 
complications, according to the Clavien-Dindo 
classification.11 Secondary outcomes were the associa-
tion of the most severe intraoperative adverse events 
with the sum of all postoperative complications, 
calculated by the comprehensive complication index,12 
postoperative length of hospital stay, length of surgery, 
and 30 day mortality. Thirty day mortality was defined 
as death within 30 days of surgery, either in hospital or 
after discharge.
All models for the primary and secondary outcomes 
were adjusted for confounders: American Society of 
Anesthesiologists physical status,21 as a summary 
measure of perioperatively relevant comorbidities; 
age; length of surgery; complexity of surgery, graded 
as one of five categories according to the British United 
Provident Association (BUPA)22 23; urgency of the 
procedure (planned or emergency); experience of the 
surgical and anaesthesia team (for a definition, see the 
statistical analysis plan in the supplementary file); and 
wound class.24 All confounders were defined according 
to biological plausibility and scientific rationale. Type 
of operation and complexity were recorded according 
to the BUPA classification.22 23 BUPA categorises 
all commonly performed surgical procedures into 
five complexity grades (minor, intermediate, major, 
major plus, and complex major; supplementary table 
S15) and has been used previously for scientific 
purposes.25 26
inter-rater reliability and practicability of classintra
An online anonymous survey (SurveyMonkey, San 
Mateo, CA, USA) of 10 fictitious case scenarios 
(supplementary table S3) describing intraoperative 
adverse events was sent to a representative sample 
of physicians from the participating centres. The 
scenarios were designed to cover a range of severity 
grades and medical specialties. The benchmark rating 
for each case scenario was determined by consensus 
of the core team. The physicians also rated the 
practicability of the instrument on a nine point scale, 
with end anchors of “very practical” and “not practical 
at all.”
statistical analysis
A multivariable hierarchical proportional odds model 
was used to investigate the association between 
the most severe intraoperative and postoperative 
adverse event considering clustering within study 
centres. The proportional odds assumption was 
mainly assessed with the Brant test. Because of the 
sparseness of the data for the higher severity grades 
for intraoperative and postoperative adverse events, 
and breach of the proportionality assumption for the 
five categories of the Clavien-Dindo system, a three 
category classification (Clavien-Dindo grade 0, grades 
I-II, and grades III-V) was used. The rationale for these 
cut-offs was to distinguish an uneventful course from 
a minor or major deviation, and was in line with cut-
offs used in most publications combining categories.16 
The consistency of the coefficients was checked by 
performing an internal validation with bootstrapping 
table 1 | classintra version 1.0 classification of intraoperative adverse events. the classification defines intraoperative adverse events as any deviation 
from the ideal intraoperative course occurring between skin incision and skin closure. any event related to surgery and anaesthesia during the index 
surgery must be considered and should be rated directly after surgery.* a requirement is that the indication for surgery and the interventions conform 
to current guidelines
grade Definition examples
Grade 0 No deviation from the ideal intraoperative course —
Grade I
Any deviation from the ideal intraoperative course: 
• Without the need for any additional treatment or intervention 
• Patient with no or mild symptoms
•  Bleeding: bleeding above average from small calibre vessel, self-limiting or definitively  
manageable without additional treatment than routine coagulation
• Injury: minimal serosal intestinal lesion, not requiring any additional treatment 
• Cautery: small burn of the skin, no treatment necessary 
• Arrhythmia: arrhythmia (eg, extrasystoles) without relevance
Grade II
Any deviation from the ideal intraoperative course: 
• With the need for any additional minor treatment or intervention 
•  Patient with moderate symptoms, not life threatening, and not 
leading to permanent disability
• Bleeding: bleeding from medium calibre artery or vein, ligation; use of tranexamic acid 
• Injury: non-transmural intestinal lesion requiring suture(s) 
• Cautery: moderate burn requiring non-invasive wound care 
•  Arrhythmia: arrhythmia requiring administration of antiarrhythmic drug,  
no haemodynamic effect
Grade III
Any deviation from the ideal intraoperative course:
•  With the need for any additional moderate treatment  
or intervention
•  Patient with severe symptoms, potentially life threatening or 
potentially leading to permanent disability
•  Bleeding: bleeding from large calibre artery or vein with transient haemodynamic instability, 
ligation or suture; blood transfusion
• Injury: transmural intestinal lesion requiring segmental resection 
• Cautery: severe burn requiring surgical debridement 
•  Arrhythmia: arrhythmia requiring administration of antiarrhythmic drug, transient  
haemody namic effect
Grade IV
Any deviation from the ideal intraoperative course:  
•  With the need for any additional major and urgent treatment or 
intervention
•  Patient with life threatening symptoms or leading to permanent 
disability
•  Bleeding: life threatening bleeding with splenectomy; massive blood transfusion; stay at 
intensive care unit
• Injury: injury of central artery or vein requiring extended intestinal resection 
•  Cautery: life threatening burn injury by cautery leading to  
fire requiring intensive care treatment
•  Arrhythmia: arrhythmia requiring electroconversion, defibrillation,  
or admission to intensive care
Grade V Any deviation from the ideal intraoperative course with intraoper-ative death of the patient —
*These events were not defined as intraoperative adverse events: sequelae, failures of cure, events related to the underlying disease, incorrect site or incorrect patient surgery, or errors in 
indication.
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methods, with 100 replications of samples from 2520 
patients. A model with a binary endpoint (any v no 
postoperative complication) was used as a sensitivity 
analysis.
The association of the most severe intraoperative 
adverse event and the weighted sum of all postoperative 
complications (comprehensive complication index)12 
was explored with a multivariable two level mixed effect 
regression model accounting for correlation between 
patients from the same study centre. Associations 
between the most severe intraoperative adverse event 
and the secondary endpoints of postoperative length 
of hospital stay and length of surgery were investigated 
in a multivariable two level mixed effect log linear 
regression model. The coefficients of the log linear 
regression models were back transformed to improve 
the interpretability of the results showing percentage 
changes27 in hospital days or duration of surgery for 
one unit increase in the corresponding covariate.
In the survey, the average agreement between 
the ratings of the physicians and the core team was 
calculated. Inter-rater reliability was assessed with the 
intraclass correlation coefficient based on the mean 
absolute agreement, estimated in a two way random 
effects model.28
The participating hospitals were a voluntary 
convenience sample. The planned sample size of 
2500 patients allowed for robust estimation in 
the multivariable models, assuming at least one 
postoperative complication in 10% of the patients (that 
is, at least 250 events; for details, see the statistical 
analysis plan in the supplementary file).
Analyses were performed with Stata 14 (StataCorp, 
College Station, TX). Further details on data manage-
ment and statistical analysis are in the statistical 
analysis plan (supplementary file).
Missing data
When an undefined complexity grade in the BUPA 
classification system (in 4% of procedures) was found, 
a grade corresponding to a similar procedure was used. 
This analysis was then compared with a complete 
case analysis. If no information was available on 
the presence of the anaesthesia resident or nurse, or 
whether they were in training or had graduated, we 
assumed that these team members were not present or 
were in training. There were no other missing values 
for outcomes or covariates, except for data on 30 day 
mortality in patients lost to follow-up.
classintra study group
The ClassIntra study group consisted of a 
multidisciplinary, international team of anaesthe-
tists, surgeons with a range of surgical specialties, 
epidemiologists, and statisticians with extensive 
expertise in perioperative care.
Patient and public involvement
This research was a multicentre collaboration 
to evaluate a newly developed classification for 
intraoperative adverse events. The data and software 
were not publicly available for analysis by patients or 
members of the public. Our protocol did not include 
patient and public involvement in the planning or 
implementation of this research. No patients were 
asked to advise on interpretation or writing up of the 
results. However, future research will evaluate the 
effect of intraoperative adverse events measured with 
ClassIntra on patient reported outcomes.
results
Patient and procedural characteristics
Of 2640 patients screened, 2520 were enrolled in 
18 secondary and tertiary centres in North America, 
Europe, and Oceania, representing 12 countries. All 
patients were recruited between 14 February 2017 
and 27 July 2018. The median number of patients 
enrolled per site was 130 (interquartile range 100-
176). The main reason for exclusion was day surgery 
(fig 1). Patients had a range of surgical procedures 
from different surgical disciplines, except ophthalmic 
surgery (table 2), with 44% (n=1090) of surgeries 
corresponding to the two highest complexity levels. 
Patient and procedural characteristics are described in 
table 2 (examples of the most frequent types of surgical 
procedures are in supplementary table S15). Baseline 
characteristics were similar in patients with and 
without intraoperative adverse events. The American 
Society of Anesthesiologists’ physical status classes, 
and the complexity of the surgical procedure, however, 
were higher in patients with an intraoperative adverse 
event.
intraoperative adverse events according to 
classintra
Of 2520 patients enrolled, 610 (24%) experienced 
778 intraoperative adverse events (table 3). The most 
severe intraoperative adverse event per patient was 
grade I in 161 patients (6.4%), grade II in 309 (12%), 
grade III in 122 (4.8%), and grade IV in 18 patients 
(0.7%). No intraoperative deaths occurred (table 3).
Postoperative complications
During the postoperative course, 2509 complications 
were seen in 838 patients (33%). Table 3 gives details 
of the severity grades and number of postoperative 
complications.
Multivariable analysis showed a gradual increase in 
the odds of a more severe postoperative complication 
with an increasing grade of the most severe intra-
operative adverse event (fig 2; supplementary table 
S5). Consistently, a stepwise increase in the sum 
of all postoperative complications (comprehensive 
complication index) with an increasing grade of 
ClassIntra was seen (supplementary table S6).
More secondary outcomes
Median postoperative length of hospital stay was 3 
days (interquartile range 2-6) in all patients, and was 
doubled in patients with at least one intraoperative 
adverse event (median 6 days; interquartile 
range 3-9 days) compared with patients with no 
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intraoperative adverse events (3; 1-5 days) (table 3). 
In the multivariable analysis, median postoperative 
length of hospital stay increased with each ClassIntra 
grade by 6.1% (95% confidence interval 2.8 to 9.3%; 
supplementary table S7).
The median length of surgery was 100 minutes 
(interquartile range 60-170) with a maximum length of 
760 minutes (table 3). The length of surgery was longer 
in patients experiencing an intraoperative adverse 
event, with an increase of 16% in median length of 
surgery with each grade increase in ClassIntra (95% 
confidence interval 13% to 18%; supplementary 
table S8). Thirty day follow-up was available for 2372 
(94%) patients (fig 1). Mortality at 30 days was 1.1% 
(n=26), with a higher incidence in patients with an 
intraoperative event (table 3 and table S9).
survey
The response rate to the survey was 83% (136/163 
physicians). About a third of respondents were 
anaesthetists and two thirds were surgeons from 
various surgical disciplines with a range of years’ 
experience (supplementary table S4). Reliability 
among physicians showed an intraclass correlation 
coefficient of 0.76 (95% confidence interval 0.59 
to 0.91). Overall agreement with the ratings of the 
core team was 61% (interquartile range 42-71%; 
supplementary figure S1), with deviation usually 
explained by physicians rating one grade lower than 
the core team. Physicians rated the practicability of 
ClassIntra as 6 out of 9 (interquartile range 5-7).
discussion
Principal findings
This international multicentre study showed that 
ClassIntra is a valid and standardised tool for assessing 
intraoperative adverse events, with high construct 
validity, given the increasing effects of severity 
grades on important patient outcomes. ClassIntra 
also showed good criterion validity and practicability 
across different surgical disciplines.
The association between severe intraoperative 
and postoperative complications, well established in 
abdominal surgery,6 8 was replicated in a heterogeneous 
population of surgical patients from a range of surgical 
disciplines. The association of intraoperative adverse 
events and postoperative length of hospital stay might 
have been mediated by postoperative complications 
(that is, more postoperative complications resulted in a 
longer stay in hospital after operation). The association 
between intraoperative adverse events and length of 
surgery was most likely related (that is, more adverse 
events might have prolonged surgery, which in turn 
could have led to more intraoperative adverse events).
strengths and limitations of the study
ClassIntra is a comprehensive classification, with a 
patient centred perspective, because it records any 
event related to anaesthesia or surgery, and grades the 
outcomes according to those relevant to the patient, 
the symptoms caused by the event, and the measures 
taken to treat the event. ClassIntra was derived from 
CLASSIC, which was developed by an interdiscipli-
nary, international group of anaesthetists, surgeons, 
epidemiologists, and statisticians.15 ClassIntra aligns 
with the Clavien-Dindo classification of postoperative 
complications,11 allowing the reporting of intra-
operative and postoperative adverse events.
Our robust study design, based on a large sample 
size involving a range of surgical disciplines, and 
on prospective multicentre data collection, implies 
good generalisability. Good generalisability always 
introduces some heterogeneity, which was accounted 
for by adjusting the analyses for the complexity of the 
surgical procedure and patient related factors. Whether 
the results are mainly driven by the largest subgroup 
of patients having an intra-abdominal procedure will 
be investigated in a secondary analysis comparing the 
results in several subgroups. The primary advantage 
of a broad classification is that it increases uniformity 
in reporting intraoperative adverse events and allows 
comparison of results between different centres and 
times. In our study, details of each intraoperative 
adverse event were collected. Our group is currently 
investigating how the additional information can be 
used to support quality improvement in the future. We 
therefore encourage adding details about the events 
and intervention specific intraoperative outcomes of 
interest to the ClassIntra grade, whenever possible 
within a framework of standardised core outcomes.29
To keep it practical and simple, the classification 
uses generic definitions of the five severity grades; 
individual judgment is necessary for interpretation. 
Assessed for eligibility



















Data available for analysis (secondary endpoint)
Data available for analysis (primary and secondary endpoints)
Patients with 30 day follow-up
2372 (94%)
120
Lost to 30 day follow-up
Unreachable









Fig 1 | Flow diagram of patients in the validation study of classintra
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Similarly, defining an event as deviation from the ideal 
intraoperative course requires personal judgment. 
Inter-rater reliability in the survey was strong and 
disagreement was mostly by one grade. We found the 
inter-rater reliability results reassuring, given that the 
physicians had various backgrounds and were grading 
table 2 | Patient and procedural characteristics for the whole study population and for subgroups with and with no intraoperative adverse events
all patients  
(n=2520)
Patients with no intraoperative 
adverse events (n=1910)




American Society of Anesthesiologists (ASA) physical status
 ASA I 503 (20) 431 (23) 72 (12) —
 ASA II 1118 (44) 852 (45) 266 (44) —
 ASA III 805 (32) 565 (30) 240 (39) —
 ASA IV       92 (3.7) 62 (3.3) 30 (4.9) —
 ASA V 2 (0.1) — 2 (0.3) —
Age (median (IQR; range))
 In adults (age ≥18; n=2340) 61 (46-72; 18-97) 60 (45-71; 18-97) 64 (49-74; 18-93) —
 In children (age <18; n=180) 9 (5-14; 0-17) 9 (5-14; 0-17) 8 (3-13; 0-16) —
Sex
 Male 1382 (55) 1038 (54) 344 (56) —
 Female 1138 (45) 872 (46) 266 (44) —
Body mass index in adults (median (IQR); n=2340) 26 (23-30) 26 (23-30) 26 (23-30) 14 (1)
Weight in children (kg; median (IQR, range); n=180) 32 (19-53; 4-137) 33 (19-54; 4-137) 26 (17-37; 7.9-85) —
Surgical discipline
 Gastrointestinal surgery 1437 (57) 1085 (57) 352 (58) —
 Orthopaedic surgery and traumatology 297 (12) 260 (14) 37 (6.1) —
 Vascular surgery 169 (6.7) 121 (6.3) 48 (7.9) —
 Urology 134 (5.3) 109 (5.7) 25 (4.1) —
 Ear, nose, throat, and maxillofacial surgery 122 (4.8) 99 (5.2) 23 (3.8) —
 Neurosurgery and spine surgery 96 (3.8) 53 (2.8) 43 (7.1) —
 Cardiac surgery 73 (2.9) 41 (2.2) 32 (5.3) —
 Paediatric surgery 54 (2.1) 48 (2.5) 6 (1.0) —
 Gynaecology 46 (1.8) 29 (1.5) 17 (2.8) —
 Obstetrics 44 (1.8) 31 (1.6) 13 (2.1) —
 Reconstructive and hand surgery 26 (1.0) 21 (1.1) 5 (0.8) —
 Thoracic surgery 22 (0.9) 13 (0.7) 9 (1.5) —
Urgency of the procedure
 Planned 2153 (85) 1627 (85) 526 (86) —
 Emergency 367 (15) 283 (15) 84 (14) —
Complexity of surgical procedure (original)
 Minor 105 (4.2) 94 (4.9) 11 (1.8) 98 (4)
 Intermediate 437 (17) 383 (20) 54 (8.9)
 Major 790 (31) 613 (32) 177 (29)
 Major plus 442 (18) 323 (17) 119 (20)
 Complex major operation 648 (26) 431 (23) 217 (36)
Additional procedure 406 (16) 266 (14) 140 (23)
Wound class
 Clean 1341 (53) 1033 (54) 308 (50) —
 Clean contaminated 1001 (40) 746 (39) 255 (42) —
 Contaminated 147 (5.8) 103 (5.4) 44 (7.2) —
 Dirty 31 (1.2) 28 (1.5) 3 (0.5) —
Operating surgeon
 Senior consultant 1662 (66) 1239 (65) 423 (69) —
 Junior consultant 544 (22) 427 (22) 117 (19) —
 Resident 314 (12) 244 (13) 70 (11) —
Assisting surgeon 2371 (94) 1781 (93) 590 (97) —
 Senior consultant 555/2371 (23) 385/1781 (22) 170/590 (29) —
 Junior consultant 578/2371 (24) 432/1781 (24) 146/590 (25) —
 Resident 1238/2371 (52) 964/1781 (54) 274/590 (46) —
Anaesthesia consultant present 2311 (92) 1746 (91) 565 (93) —
 Senior consultant 1481/2311 (64) 1112/1746 (64) 369/565 (65) —
 Junior consultant 830/2311 (36) 634/1746 (36) 196/565 (35) —
Anaesthesia resident present 1443 (57) 1017 (53) 426 (70) 1 (0.0)
Anaesthesia nurse present 1866 (74) 1405 (74) 461 (76) 2 (0.1)
 Proportion who graduated 1699 (91) 1268 (90) 431 (93) 3 (0.2)
Anaesthesia technique
 General anaesthesia 2035 (81) 1558 (82) 477 (78) —
 Regional anaesthesia 198 (7.9) 158 (8.3) 40 (6.6) —
 Combined techniques 265 (11) 176 (9.2) 89 (15) —
 Monitored anaesthesia care 22 (0.9) 18 (0.9) 4 (0.7) —
Data are number (%) unless indicated otherwise. IQR=interquartile range.
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intraoperative adverse events in different surgical 
disciplines and in anaesthesia. In clinical practice and 
in our prospective cohort study, joint assessment by 
surgeons and anaesthetists during sign-out20 should 
lower this variability and the risk of under-reporting 
and downgrading of intraoperative adverse events. 
As clinicians become more familiar with ClassIntra, 
we believe the system will be easier to use, similar to 
the experience with the Clavien-Dindo classification 
after its introduction into routine clinical practice. 
Generally, different professional backgrounds, levels 
of experience, and cultural diversity among physicians 
table 3 | Outcomes for the whole study population and for subgroups with and with no intraoperative adverse events
all patients  
(n=2520)
Patients with no intraoperative 
adverse events (n=1910)




All iAE (several events per patient possible)
 0 1910 (71) 1910 (100) — —
 I 198 (7.4) — 198 (25) —
 II 417 (16) — 417 (54) —
 III 142 (5.3) — 142 (18) —
 IV 21 (0.8) — 21 (3.0) —
 V — — — —
Total No of iAE per patient
 0 1910 (76) 1910 (100) — —
 1 485 (19) — 485 (80) —
 2 92 (3.7) — 92 (15) —
 3 27 (1.1) — 27 (4.4) —
 4 3 (0.1) — 3 (0.5) —
 5 2 (0.1) — 2 (0.3) —
 6 1 (0.0) — 1 (0.2) —
Transfer after operation 677 (27) 403 (21) 274 (45) —
 Intermediate care unit 347/677 (51) 244/403 (61) 103/274 (38) —
 Intensive care unit 330/677 (49) 159/403 (39) 171/274 (62) —
 Unplanned 45/677 (6.7) 6/403 (1.5) 39/274 (14) —
Length of surgery (minutes; median (IQR, range)) 100 (60-170, 4-760) 90 (55-147, 4-760) 151 (93-240, 12-673) —
Most severe postoperative complication per patient
 0 1682 (67) 1367 (72) 315 (52) —
 I 349 (14) 257 (13) 92 (15) —
 II 277 (11) 162 (8.5) 115 (19) —
 IIIa 72 (2.9) 45 (2.4) 27 (4.4) — 
 IIIb 55 (2.2) 40 (2.1) 15 (2.5) —
 IVa 53 (2.1) 23 (1.2) 30 (4.9) —
 IVb 7 (0.3) 3 (0.2) 4 (0.7) —
 V 25 (1.0) 13 (0.7) 12 (2.0) —
All postoperative complications (several events per patient possible)
 I 1106 (44) 747 (48) 359 (37) —
 II 983 (39) 557 (36) 426 (44) —
 IIIa 160 (6.4) 94 (6.1) 66 (6.8) —
 IIIb 105 (4.2) 72 (4.7) 33 (3.4) —
 IVa 110 (4.4) 51 (3.3) 59 (6.1) —
 IVb 20 (0.8) 9 (0.6) 11 (1.1) —
 V 25 (1.0) 13 (0.8) 12 (1.2) —
Total No of postoperative complications per patient
 None 1682 (67) 1367 (72) 315 (52) —
 1 412 (16) 288 (15) 124 (20) —
 2-5 329 (13) 198 (10) 131 (21) —
 >5 97 (3.9) 57 (3.0) 40 (6.6) —
Reoperation
 No 2421 (96) 1844 (97) 577 (95) —
 Any reoperation 99 (3.9) 66 (3.5) 33 (5.4) —
Total No of reoperations
 1 68 (69) 46 (70) 22 (67) —
 2 16 (16) 11 (17) 5 (15) —
 3 6 (6.1) 4 (6.1) 2 (6.1) —
 4 8 (8.1) 5 (7.6) 3 (9.1) —
 5 1 (1.0) ·· 1 (3.0) —
Postoperative length of hospital stay (days; median (IQR, range)) 3 (2-6, 0-191) 3 (1-5, 0-106) 6 (3-9, 1-191) —
Total length of hospital stay (days; median (IQR, range)) 4 (2-8, 1-193) 3 (2-7, 1-113) 7 (3-11, 1-193) —
Stay during postoperative course 68 (2.7) 40 (2.1) 28 (4.6) —
 Intermediate care unit 18 (26) 15 (38) 3 (11) —
 Intensive care unit 50 (74) 25 (63) 25 (89) —
30 day mortality 26 (1.1) 13 (0.7) 13 (2.1) 148 (5.9)
Data are number (%) unless stated otherwise. IQR=interquartile range; iAE= intraoperative adverse events.
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might have explained the practicability ratings of less 
than five in 25% of the survey participants and ratings 
greater than seven in another 25%. 
Because our project was conducted as part of daily 
clinical practice, having an independent person to 
record intraoperative and postoperative events would 
not have been feasible, and blinding of those assessing 
postoperative outcomes would have been unethical. 
The direction of the potential bias is unclear, however, 
as under-reporting and over-reporting could, theoreti-
cally, occur. Under-reporting and downgrading of 
complications is a problem in healthcare settings and 
should be handled with a positive, non-discriminative 
learning culture. A classification for complications 
should be sensitive enough to monitor and detect 
rating variability caused by downgrading.30 31
Our secondary endpoints included length of hospital 
stay. We acknowledge that this outcome might be 
affected by the variables included in the model (that is, 
the most severe intraoperative adverse event and the 
confounding variables) and also by cultural norms, 
logistical issues, and economic considerations. This 
analysis should be viewed as supporting evidence as it 
showed consistent stepwise increasing association in 
alignment with all other postoperative endpoints.
Findings in relation to other studies
Other classification systems for intraoperative 
adverse events have been published.32 Kaafarani and 
colleagues8 classified intraoperative adverse events 
into six grades. Grades I-IV depend on the intervention 
required to treat the intraoperative adverse events and 
the deviation from the planned procedure. Grade V 
refers to an intraoperative injury missed during surgery 
and requiring re-operation within seven days. Grade 
VI refers to intraoperative death. This classification 
was based on a retrospective analysis of routinely 
collected data in selected patients with accidental 
puncture or laceration. Although their classification 
approach differs considerably from ClassIntra, the 
authors confirmed an association between major 
intraoperative and postoperative adverse events.8 Our 
study was based on prospective data in unselected 
patients from a range of surgical interventions and 
considered any event related to surgery or anaesthesia. 
We did not include re-operation because of the 
difficulty in determining if an intraoperative injury or 
a postoperative complication was responsible for the 
re-operation.
A classification of surgical intraoperative adverse 
events for laparoscopic surgery was proposed, with 
five grades similar to ClassIntra, but excluded adverse 
events related to anaesthesia.33 Others used readily 
available information, such as quality indicators of 
the intraoperative period, to predict postoperative 
outcome. Coulson and colleagues estimated the acute 
risk change in the probability of death before and 
after operation based on two validated risk scores.34 35 
The 10 point Apgar score for surgery was developed 
in patients having a colectomy and was evaluated 
in a broader surgical population.36 37 Prediction of 
postoperative complications was based on estimated 
blood loss, lowest mean arterial pressure, and heart 
rate. Although both scores showed good predictive 
ability, they provided only a surrogate marker for 
adverse intraoperative events.
ClassIntra
  Grade I     0
  Grade II     0
  Grade III     0
  Grade IV     0
Age (per decade increase)
ASA class (ASA III-V    ASA I-II)
Complexity of surgery 
  Intermediate     minor
  Major     minor
  Major plus     minor
  Complex major     minor
Length of surgery (per 10 minute increase)
Urgency (emergency     planned)
Wound class (non-clean     clean)
Experience of surgical team












0.99 (0.69 to 1.42)
1.39 (0.97 to 2.00)
2.62 (1.31 to 5.26)
3.81 (1.19 to 12.2)
1.04 (0.99 to 1.09)
1.70 (1.40 to 2.06)
0.79 (0.52 to 1.19)
0.85 (0.50 to 1.45)
1.20 (0.74 to 1.94)
1.27 (0.79 to 2.04)
1.05 (1.03 to 1.07)
1.57 (1.04 to 2.35)
1.20 (0.99 to 1.46)
0.84 (0.69 to 1.03)
0.88 (0.80 to 0.96)
0.5 2 51 10




Fig 2 | Multivariable hierarchical proportional odds model for the most severe postoperative complications according to the clavien-Dindo 
classification (three categories for outcome: no postoperative complications, grades i-ii, and grades iii-v), adjusted for the most relevant 
confounders. asa=american society of anesthesiologists’ physical status level
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Bothner and colleagues developed an incidents, 
events, and complications scale related to anaesthesia, 
based on a set of 63 events with five ascending severity 
grades depending on the effect on postoperative 
care and outcome.38 The scale was implemented for 
quality assurance and covered the whole period of 
anaesthesia, from induction to discharge to the ward 
or to the intensive care unit. Their reported rate of 22% 
adverse events was relatively higher than our findings 
where events related to anaesthesia and surgery were 
taken together, which could partly be explained by the 
restricted period covered in our study.
implications for clinicians or policy makers
Patient safety in the perioperative period has gained 
considerable interest and successful interventions, 
such as the reduction in morbidity and mortality after 
introduction of a surgical safety checklist, have been 
seen.20 ClassIntra covers a major unmet need, as the 
first prospectively validated classification system 
that is simple and generally applicable to all surgical 
disciplines, to our knowledge. It takes a holistic 
view by integrating any adverse event, regardless of 
origin. Also, because innovative surgical techniques 
are increasingly complex and implemented quickly, 
preventing morbidity during the implementation 
period is important.39 ClassIntra should be included in 
routine practice to alert the postoperative care team to 
patients with intraoperative adverse events and at risk 
of further postoperative complications.
Future research
We acknowledge that our definition of intraoperative 
adverse events included only the time between skin 
incision and closure. Induction of and emergence 
from anaesthesia were not covered, which can have 
risks for more adverse events. Assessing the construct 
validity of a new classification is an ongoing process, 
which requires confirmation by more convergent 
and discriminative validity assessments to increase 
credibility. In future research, we will evaluate the 
properties of ClassIntra extending the assessment 
period to include the periods related to anaesthesia 
(that is, induction and emergence), focusing on patient 
reported outcomes, thus expanding the hypothetical 
construct for assessing validity.
ClassIntra can be used in clinical research as a 
defined core outcomes measure as it provides standard 
definitions, allowing accurate communication of 
research results and comparisons across research 
studies.11 40 ClassIntra can help evaluate the origin 
of the complications during the surgical procedure, 
providing more granularity to the complication profile 
for each procedure or surgical unit. Also, ClassIntra 
can be used in critical incidence reporting systems,41 
for measuring individual performance in educational 
settings and system performance for benchmarking 
by institutions, and for outcome research. Future 
implementation studies should evaluate this tool 
in daily clinical practice for risk stratification of 
postoperative care or for planning resources and 
hospital capacities, in view of the increase in 
postoperative length of stay with the increasing 
severity of the ClassIntra grade. For day surgeries, 
the risk of perioperative complications is minimal. 
Future research should investigate whether assessing 
intraoperative complications is associated with early 
visits to the general practitioner or readmission.
conclusion
ClassIntra version 1.0 is a validated and standardised 
tool to quantify and qualify intraoperative adverse 
events in clinical practice and research. It showed 
good reliability and practicability for all surgical 
disciplines and for anaesthesia. We reproduced the 
well established association between the severity 
grade for intraoperative adverse events and important 
postoperative outcomes. Hence ClassIntra is a useful 
tool for recording intraoperative adverse events and 
should be incorporated into the perioperative surgical 
safety checklist to highlight recurrent and potentially 
avoidable complications. ClassIntra could improve the 
technical aspects of intraoperative care and provide 
clarity in audits of practice.
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